Presentation TCT 2013 Which Aortic Stenosis Patients Are Too Low-Risk for TAVR? Presenter: Raj Makkar October 27, 2013
Presentation TCT 2013 Strategies for Measuring Technical Success to Facilitate Ideal Patient Selection in Renal Denervation Presenter: Paul Sobotka October 27, 2013
Presentation TCT 2013 Who Should Receive the New Chronic Oral Anticoagulants? Which One? Presenter: Christopher Granger October 27, 2013
Presentation TCT 2013 Ethanol Injection for Renal Denervation (Ablative Solutions) Presenter: Tim Fischell October 27, 2013
Presentation TCT 2013 TCT-133. The Multilayer Flow Modulator Stent for the Treatment of Peripheral and Visceral Aneuryms Presenter: Michel Henry October 27, 2013
Presentation TCT 2013 Should the CLEVER Trial Results Materially Affect Decision-Making in Iliac Disease? Presenter: Herbert Aronow October 27, 2013
Presentation TCT 2013 Antithrombin Therapy (GP IIb/IIIa inhibitors) in Patients with ACS and Those Undergoing PCI Presenter: Sripal Bangalore October 27, 2013
Presentation TCT 2013 CTA in the Emergency Department for Evaluation of Possible ACS: The Triple Rule Out Presenter: Stamatios Lerakis October 27, 2013
Presentation TCT 2013 Is ABSORB a Workhorse DES? Real-world Perspectives I Presenter: Antonio Colombo October 27, 2013
Presentation TCT 2013 Renal Denervation for Glycemic Control and Obstructive Sleep Apnea: An Update Presenter: Felix Mahfoud October 27, 2013